Literature DB >> 30378105

Interaction between mesenchymal stromal cell-derived extracellular vesicles and immune cells by distinct protein content.

Soura Mardpour1,2, Amir Ali Hamidieh3, Sara Taleahmad2, Farzaneh Sharifzad4, Adeleh Taghikhani5, Hossein Baharvand2,6.   

Abstract

Mesenchymal stromal cells (MSCs) can effectively contribute to tissue regeneration inside the inflammatory microenvironment mostly through modulating immune responses. MSC-derived extracellular vesicles (MSC-EVs) display immunoregulatory functions similar to parent cells. Interactions between MSC-EVs and immune cells make them an ideal therapeutic candidate for infectious, inflammatory, and autoimmune diseases. These properties of MSC-EVs have encouraged researchers to perform extensive studies on multiple factors that mediate MSC-EVs immunomodulatory effects. Investigation of proteins involved in the complex interplay of MSC-EVs and immune cells may help us to better understand their functions. Here, we performed a comprehensive proteomic analysis of MSC-EVs that was previously reported by ExoCarta database. A total of 938 proteins were identified as MSC-EV proteome using quantitative proteomics techniques. Kyoto Encyclopedia of Genes and Genomes analysis demonstrates that ECM-receptor interaction, focal adhesion, and disease-specific pathways are enriched in MSC-EVs. By detail analysis of proteins presence in immune system process, we found that expression of some cytokines, chemokines, and chemokine receptors such as IL10, HGF, LIF, CCL2, VEGFC, and CCL20, which leads to migration of MSC-EVs to injured sites, suppression of inflammation and promotion of regeneration in inflammatory and autoimmune diseases. Also, some chemoattractant proteins such as CXCL2, CXCL8, CXCL16, DEFA1, HERC5, and IFITM2 were found in MSC-EV proteome. They may actively recruit immune cells to the proximity of MSC or MSC-EVs, may result in boosting immune response under specific circumstances, and may have protective role in infectious diseases. In this review, we summarize available information about immunomodulation of MSC-EVs with particular emphasis on their proteomics analysis.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  exosome; immune response; inflammation; mesenchymal stromal cell; proteomics

Mesh:

Substances:

Year:  2018        PMID: 30378105     DOI: 10.1002/jcp.27669

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  43 in total

Review 1.  Extracellular vesicles, news about their role in immune cells: physiology, pathology and diseases.

Authors:  J Meldolesi
Journal:  Clin Exp Immunol       Date:  2019-03-11       Impact factor: 4.330

Review 2.  Mesenchymal stem cell-derived exosomes: a promising vector in treatment for diabetes and its microvascular complications.

Authors:  Xinjie Cui; Liangxi Zhu; Ruixia Zhai; Bin Zhang; Fanyong Zhang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

Review 3.  Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential.

Authors:  Na Song; Martijn Scholtemeijer; Khalid Shah
Journal:  Trends Pharmacol Sci       Date:  2020-07-22       Impact factor: 14.819

Review 4.  Therapeutically harnessing extracellular vesicles.

Authors:  Lesley Cheng; Andrew F Hill
Journal:  Nat Rev Drug Discov       Date:  2022-03-02       Impact factor: 84.694

5.  Adult-derived human liver stem/progenitor cells as sensors of inflammation: a potential therapy for liver disorders.

Authors:  Soura Mardpour; Amir Ali Hamidieh
Journal:  Hepatobiliary Surg Nutr       Date:  2019-06       Impact factor: 7.293

6.  Priming With Toll-Like Receptor 3 Agonist Poly(I:C) Enhances Content of Innate Immune Defense Proteins but Not MicroRNAs in Human Mesenchymal Stem Cell-Derived Extracellular Vesicles.

Authors:  Lisa M Pierce; Wendy E Kurata
Journal:  Front Cell Dev Biol       Date:  2021-05-24

7.  Release and Actions of Inflammatory Exosomes in Pulmonary Emphysema: Potential Therapeutic Target of Acupuncture.

Authors:  Yao Zou; Owais M Bhat; Xinxu Yuan; Guangbi Li; Dandan Huang; Yi Guo; Dan Zhou; Pin-Lan Li
Journal:  J Inflamm Res       Date:  2021-07-24

Review 8.  Harnessing the ECM Microenvironment to Ameliorate Mesenchymal Stromal Cell-Based Therapy in Chronic Lung Diseases.

Authors:  Linda Elowsson Rendin; Anna Löfdahl; Måns Kadefors; Zackarias Söderlund; Emil Tykesson; Sara Rolandsson Enes; Jenny Wigén; Gunilla Westergren-Thorsson
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

Review 9.  Review of the potential of mesenchymal stem cells for the treatment of infectious diseases.

Authors:  Amit Sharma; Anuja Chakraborty; Bithiah Grace Jaganathan
Journal:  World J Stem Cells       Date:  2021-06-26       Impact factor: 5.326

Review 10.  Exosomal delivery of therapeutic modulators through the blood-brain barrier; promise and pitfalls.

Authors:  Reza Rahbarghazi; Emel Sokullu; Morteza Heidarzadeh; Yasemin Gürsoy-Özdemir; Mehmet Kaya; Aysan Eslami Abriz; Amir Zarebkohan
Journal:  Cell Biosci       Date:  2021-07-22       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.